Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Letters

Volume 30—2024

Volume 30, Number 2—February 2024

Cover of issue Volume 30, Number 2—February 2024

No Evidence for Clade I Monkeypox Virus Circulation, Belgium [PDF - 230 KB - 1 page]
L. Liesenborghs et al.
EID Liesenborghs L, Coppens J, Van Dijck C, Brosius I, De Baetselier I, Vercauteren K, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerg Infect Dis. 2024;30(2):402. https://doi.org/10.3201/eid3002.231746
AMA Liesenborghs L, Coppens J, Van Dijck C, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases. 2024;30(2):402. doi:10.3201/eid3002.231746.
APA Liesenborghs, L., Coppens, J., Van Dijck, C., Brosius, I., De Baetselier, I., Vercauteren, K....Van Esbroeck, M. (2024). No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases, 30(2), 402. https://doi.org/10.3201/eid3002.231746.

Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan [PDF - 236 KB - 1 page]
K. Iwata
EID Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerg Infect Dis. 2024;30(2):403. https://doi.org/10.3201/eid3002.230827
AMA Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases. 2024;30(2):403. doi:10.3201/eid3002.230827.
APA Iwata, K. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases, 30(2), 403. https://doi.org/10.3201/eid3002.230827.

Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response) [PDF - 474 KB - 2 pages]
T. Aita et al.
EID Aita T, Sando E, Katoh S, Hamaguchi S, Fujita H, Kurita N. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerg Infect Dis. 2024;30(2):403-404. https://doi.org/10.3201/eid3002.231465
AMA Aita T, Sando E, Katoh S, et al. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases. 2024;30(2):403-404. doi:10.3201/eid3002.231465.
APA Aita, T., Sando, E., Katoh, S., Hamaguchi, S., Fujita, H., & Kurita, N. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases, 30(2), 403-404. https://doi.org/10.3201/eid3002.231465.

Volume 30, Number 1—January 2024

Cover of issue Volume 30, Number 1—January 2024

Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany [PDF - 229 KB - 1 page]
J. de Bellocq et al.
EID de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerg Infect Dis. 2024;30(1):205. https://doi.org/10.3201/eid3001.230334
AMA de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases. 2024;30(1):205. doi:10.3201/eid3001.230334.
APA de Bellocq, J., Baird, S., & Fornůsková, A. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases, 30(1), 205. https://doi.org/10.3201/eid3001.230334.

Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response) [PDF - 236 KB - 2 pages]
C. Mehl et al.
EID Mehl C, Wylezich C, Geiger C, Schauerte N, Mätz-Rensing K, Nesseler A, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerg Infect Dis. 2024;30(1):205-206. https://doi.org/10.3201/eid3001.231521
AMA Mehl C, Wylezich C, Geiger C, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases. 2024;30(1):205-206. doi:10.3201/eid3001.231521.
APA Mehl, C., Wylezich, C., Geiger, C., Schauerte, N., Mätz-Rensing, K., Nesseler, A....Ulrich, R. G. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases, 30(1), 205-206. https://doi.org/10.3201/eid3001.231521.

SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan [PDF - 276 KB - 2 pages]
H. Cheng et al.
EID Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerg Infect Dis. 2024;30(1):206-207. https://doi.org/10.3201/eid3001.230208
AMA Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases. 2024;30(1):206-207. doi:10.3201/eid3001.230208.
APA Cheng, H., Akhmetzhanov, A. R., & Dushoff, J. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases, 30(1), 206-207. https://doi.org/10.3201/eid3001.230208.

SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response) [PDF - 252 KB - 1 page]
T. Ogata and H. Tanaka
EID Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerg Infect Dis. 2024;30(1):207. https://doi.org/10.3201/eid3001.231487
AMA Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases. 2024;30(1):207. doi:10.3201/eid3001.231487.
APA Ogata, T., & Tanaka, H. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases, 30(1), 207. https://doi.org/10.3201/eid3001.231487.
Page created: November 07, 2023
Page updated: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external